United States (USA) Intravenous (IV) Equipments Market Overview, 2031

The United States has one of the largest and most technologically advanced healthcare systems globally. The extensive network of hospitals, clinics, and healthcare facilities contributes to a substantial demand for IV equipment for various medical procedures and treatments. The prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, is relatively high in the United States. Many of these conditions require on-going treatment and management, often involving the use of IV equipment for medication administration and therapeutic interventions. The U.S. is a global leader in medical research and development. Continuous innovation in healthcare technologies, including IV equipment, is a result of substantial investment in research and collaboration between academic institutions, healthcare providers, and industry stakeholders. The regulatory environment in the U.S., governed by the Food and Drug Administration (FDA), ensures that IV equipment meets stringent safety and efficacy standards. The FDA approval process helps build confidence in the quality and reliability of IV products, making the U.S. market a preferred destination for both domestic and international manufacturers. On-going investments in healthcare infrastructure, including the adoption of electronic health records and integrated healthcare systems, create a conducive environment for the implementation of advanced IV technologies. This infrastructure supports seamless communication and coordination in patient care. Demographic factors, such as an aging population, contribute to the demand for healthcare services, including IV therapy. The aging demographic often requires treatments for chronic conditions, surgeries, and other medical interventions that involve the use of IV equipment.
According to the research report, "US Intravenous Equipment Market Overview, 2031," published by Bonafide Research, the US Intravenous Equipment market is anticipated to grow at more than 5.48% CAGR from 2026 to 2031.The IV equipment market has seen a continuous influx of technological innovations. This includes the development of smart infusion pumps, which offer features such as dose error reduction systems, wireless connectivity for remote monitoring, and integration with electronic health records (EHRs). These advancements aim to enhance patient safety, reduce medication errors, and improve overall efficiency. Integration of IV equipment with healthcare information technology (IT) systems is becoming more prevalent. This includes connectivity with EHRs, allowing for seamless data exchange, better documentation, and improved coordination of care among healthcare providers. There has been a gradual shift toward disposable IV products, including IV catheters and tubing. Disposable items reduce the risk of infection and contribute to the overall safety of IV therapy. Healthcare facilities are increasingly adopting single-use products to enhance infection control measures. The rise of telemedicine has led to an increased focus on remote consultations. IV equipment that can be remotely monitored and adjusted is becoming more relevant, allowing healthcare providers to make real-time decisions even when patients are not physically present in healthcare facilities.

IV catheters represent the most widely used product type, as they are the foundational component of almost every IV procedure, ranging from routine fluid delivery to complex drug administration. Their high usage is driven by frequent hospital admissions, emergency care, and outpatient treatments. IV infusion pumps follow closely and are among the most critical revenue-generating products due to their advanced functionality, accuracy, and safety features. These pumps are extensively used in intensive care units, oncology treatments, and long-term therapies, making them a leading technology-driven segment. IV administration sets and solutions also account for substantial usage, as they are required alongside catheters and pumps for effective fluid and medication delivery, creating consistent demand due to their consumable nature. IV needles and syringes continue to see strong utilization because they are essential for injections, blood withdrawal, and medication preparation, although their growth is comparatively moderate due to standardization and cost sensitivity. IV securement devices are gaining increased attention as healthcare providers focus on reducing catheter-related complications and improving patient comfort, driving gradual but steady adoption. Stopcocks and check valves play a supporting yet essential role in fluid management systems, especially in multi-line setups, though their usage is largely dependent on procedural complexity. Other IV-related products, including specialty accessories and safety-enhanced components, contribute to niche demand driven by innovation and evolving clinical protocols.

By application, hospitals and clinics, including dialysis centers, represent the leading segment in terms of IV equipment usage, driven by high patient footfall, complex medical procedures, and continuous demand for intravenous therapy. These settings rely heavily on IV equipment for surgeries, emergency care, chronic disease management, chemotherapy, and renal treatments, making them the primary consumers of both disposable and capital-intensive IV devices. Dialysis centers, in particular, require repeated and long-duration IV access, significantly contributing to consistent equipment utilization. Ambulatory surgical centers (ASCs) form a rapidly growing segment, supported by the increasing shift toward outpatient and minimally invasive procedures. These centers use IV equipment for anesthesia delivery, pain management, and post-operative recovery, favoring efficient, compact, and easy-to-operate devices that support faster patient turnover. Home care settings are emerging as an increasingly important application area due to the rise in home-based treatments and patient preference for care outside traditional facilities. IV equipment in home care is primarily used for long-term therapies such as antibiotics, hydration, nutritional support, and palliative care, with strong demand for portable, user-friendly, and safe devices. Although home care currently trails institutional settings in total usage, it represents a high-growth application segment. Other applications, including long-term care facilities and emergency response services, contribute to steady baseline demand.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Intravenous Equipments Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation



By Product Type
• IV Catheters
• IV Infusion Pumps
• IV Securement Devices
• IV Administration Sets & Solutions
• IV Needles & Syringes
• Stopcocks & Check Valves
• Others

By Application
• Hospitals & Clinics/Dialysis Centers
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Others